Gavi re­ports 're­bound' year for child­hood vac­ci­na­tions

Fol­low­ing a his­toric back­slide in rou­tine child­hood vac­ci­na­tions amid the pan­dem­ic, Gavi, the Vac­cine Al­liance, said pre­lim­i­nary da­ta sug­gest 2022 was a “year of re­bound.”

The glob­al health part­ner­ship re­port­ed rough­ly 80% cov­er­age for a third dose of the diph­the­ria-tetanus-per­tus­sis-con­tain­ing vac­cine (DTP3) in 57 of the world’s low­est-in­come coun­tries, ac­cord­ing to ear­ly da­ta. DTP3 im­mu­niza­tion is a mark­er used to as­sess child­hood vac­ci­na­tion cov­er­age. That’s an in­crease of three per­cent­age points, fol­low­ing a drop of five per­cent­age points dur­ing the pan­dem­ic, ac­cord­ing to Gavi.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER